Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.
Smolen
J S
JS
University of Vienna, Berlin. smj@2me.khl.magwien.gv.at
Breedveld
F C
FC
Burmester
G R
GR
Combe
B
B
Emery
P
P
Kalden
J R
JR
Klareskog
L
L
Maini
R N
RN
Numo
R
R
van De Putte
L B
LB
van Riel
P L
PL
Rodriguez-Valverde
V
V
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D006801:Humans; D010147:Pain Measurement; D018579:Patient Selection; D010808:Physical Examination; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha